Inventiva (IVEVF) Free Cash Flow (2019 - 2025)
Inventiva (IVEVF) posted Free Cash Flow of $121.7 million for Q2 2025, up 335.0% on a QoQ basis from -$51.8 million in Q2 2024, and up 335.0% year-over-year from $28.0 million in Q2 2024.
Analysis
Inventiva (IVEVF) Free Cash Flow (2019 - 2025) Analysis & Trends
Inventiva has reported Free Cash Flow for 6 years, with the latest figure at $121.7 million in Q2 2025.
- On a quarterly basis, Free Cash Flow rose 335.0% year-over-year to $121.7 million in Q2 2025; TTM through Jun 2025 was $16.4 million, a 112.84% increase from a year earlier, with the FY2025 full-year figure at -$121.8 million, down 33.17% from the prior year.
- Free Cash Flow was $121.7 million for Q2 2025 at Inventiva, up from -$51.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $121.7 million in Q2 2025, with the low at -$51.8 million in Q2 2024.
- Average Free Cash Flow over 4 years is -$4.2 million, with a median of -$22.5 million recorded in 2021.
- The sharpest annual moves came in 2021 and 2025: Free Cash Flow sank 262.03% in 2021, then surged 335.0% in 2025.
- Over 4 years, Free Cash Flow stood at -$22.5 million in 2021, then decreased by 17.76% to -$26.4 million in 2022, then sank by 95.78% to -$51.8 million in 2024, then soared by 335.0% to $121.7 million in 2025.
- The last three Free Cash Flow figures came in at $121.7 million (Q2 2025), -$51.8 million (Q2 2024), and -$26.4 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 302.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | -389.61 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 495.25 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 205.60 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 121.69 Mn |
| Jun 30, 2024 | -51.78 Mn |
| Dec 31, 2022 | -26.45 Mn |
| Sep 22, 2022 | -27.05 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Jun 30, 2021 | -14.32 Mn |
| Mar 31, 2021 | -9.34 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Mar 31, 2020 | -3.95 Mn |
| Dec 31, 2019 | -20.50 Mn |